Richard A. Rode

Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects

W. P. T. James, Ian D. Caterson, Walmir Coutinho et al. · New England Journal of Medicine · 2010 · 934 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +9

Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease

D. William Cameron, Margo Heath‐Chiozzi, Sven A. Danner et al. · The Lancet · 1998 · 542 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +10

Association Between Antiretroviral Exposure and Renal Impairment Among HIV-Positive Persons With Normal Baseline Renal Function: the D:A:D Studya

Lene Ryom, Amanda Mocroft, Ole Kirk et al. · The Journal of Infectious Diseases · 2013 · 294 citations · Full text

Public Health, Infectious Diseases, Nephrology +17

Identification of Genotypic Changes in Human Immunodeficiency Virus Protease That Correlate with Reduced Susceptibility to the Protease Inhibitor Lopinavir among Viral Isolates from Protease Inhibitor-Experienced Patients

Dale J. Kempf, Jeffrey D. Isaacson, Martin King et al. · Journal of Virology · 2001 · 233 citations

Life Sciences, Genetics, Infectious Diseases +17

The duration of viral suppression during protease inhibitor therapy for HIV-1 infection is predicted by plasma HIV-1 RNA at the nadir

Dale J. Kempf, Richard A. Rode, Yi Xu et al. · AIDS · 1998 · 224 citations

Life Sciences, Infectious Diseases, Pharmacology +17